This mechanism aligns with the “integrin-ECM mechanical signal axis” model proposed by the Chastney MR team (18), but this study is the first to reveal the synergistic effect of the PI3K/AKT signaling pathway and integrins in pancreatic cancer and propose a combined targeting therapeutic strategy. Here, AKT1 is linked to pancreatic neoplasm.